Bravecto Chewable Tablets

The active ingredient in Bravecto, Fluralaner, an ectoparasiticide belonging to the isoxazoline group, is systemically active against fleas and ticks (black legged tick, American dog tick, and brown dog tick), delivering protection for up to 12 full weeks. It also kills lone star ticks for 8 weeks. Bravecto Chewable Tablets are presented in a palatable flavored chew that dogs accept readily.

Up to 12-week protection against fleas and ticks in an oral chew.
The active substance of Bravecto, fluralaner, a new ectoparasiticide belonging to the isoxazoline group, is systemically active against fleas and ticks (black legged tick, American dog tick, and brown dog tick), delivering protection for up to 12 full weeks. It also kills lone star ticks for eight weeks. Presented in a highly palatable flavored chew that dogs accept readily.
The product can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis as a direct result of eliminating flea infestations.

Advantages

  • Consistent, broad-spectrum and long-lasting efficacy against both fleas and ticks
  • Kills 100% of newly arriving fleas within 24 hours for 12 weeks1
  • Kills three tick species for 12 weeks
  • Rapid onset of action and speed of kill
  • Starts killing fleas within two hours after administration2
  • Kills 100% of fleas within 12 hours of dosing3

Maximizes owner compliance while reducing protection gaps that can occur with monthly remedies.

Packaging Quantities

Packaged as a single tablet available for miniature, small, medium, large and extra large dogs.

1  Data on file. Merck Animal Health, Summit, NJ. 2013. 2  Bravecto [prescribing information]. Summit, NJ: Merck Animal Health; 2014. 3  Freedom of Information Summary, NADA 141-426. Approved May 15, 2014.